Anti-inflammatory treatments have improved the prognoses of many patients in chronic inflammatory conditions, the most notable example being biologics such as tumor necrosis factor (TNF)-inhibitors in RA and other autoimmune conditions (9). The gene discussed is TNF; the disease is rheumatoid arthritis.